[go: up one dir, main page]

EA201190050A1 - COMPOSITION KVETIAPINA - Google Patents

COMPOSITION KVETIAPINA

Info

Publication number
EA201190050A1
EA201190050A1 EA201190050A EA201190050A EA201190050A1 EA 201190050 A1 EA201190050 A1 EA 201190050A1 EA 201190050 A EA201190050 A EA 201190050A EA 201190050 A EA201190050 A EA 201190050A EA 201190050 A1 EA201190050 A1 EA 201190050A1
Authority
EA
Eurasian Patent Office
Prior art keywords
kvetiapina
composition
quetiapine
salt
pharmaceutical composition
Prior art date
Application number
EA201190050A
Other languages
Russian (ru)
Other versions
EA020477B1 (en
Inventor
Матей Павли
Ерней Задник
Франц Врецер
Роберт Писек
Саса Баумгартнер
Рок Дреу
Одон Планинсек
Original Assignee
Крка, Товарна Здравил, Д. Д., Ново Место
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Крка, Товарна Здравил, Д. Д., Ново Место filed Critical Крка, Товарна Здравил, Д. Д., Ново Место
Publication of EA201190050A1 publication Critical patent/EA201190050A1/en
Publication of EA020477B1 publication Critical patent/EA020477B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Фармацевтическая композиция, содержащая твердую матричную систему кветиапина или его соли и ненабухающий анионный полимер.A pharmaceutical composition containing the solid matrix system of quetiapine or its salt and a non-swellable anionic polymer.

EA201190050A 2008-11-26 2009-11-26 Quetiapine composition EA020477B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200800291 2008-11-26
SI200900072 2009-03-18
PCT/EP2009/008431 WO2010066342A1 (en) 2008-11-26 2009-11-26 Quetiapine composition

Publications (2)

Publication Number Publication Date
EA201190050A1 true EA201190050A1 (en) 2012-02-28
EA020477B1 EA020477B1 (en) 2014-11-28

Family

ID=41562690

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201190050A EA020477B1 (en) 2008-11-26 2009-11-26 Quetiapine composition

Country Status (3)

Country Link
EP (1) EP2355804A1 (en)
EA (1) EA020477B1 (en)
WO (1) WO2010066342A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2402342T3 (en) 2008-08-01 2013-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Quetiapine Composition
WO2013074048A2 (en) * 2011-08-08 2013-05-23 Mahmut Bilgic Tablet forms comprising quetiapine fumarate
DE102011115690A1 (en) 2011-10-11 2013-04-11 Acino Pharma Ag Quetiapine-containing formulations
US20150231080A1 (en) * 2012-09-10 2015-08-20 Pharmathen S.A. Pharmaceutical composition comprising an atypical antipsychotic agent and method for the preparation thereof
JP2021512924A (en) * 2018-02-08 2021-05-20 タイワンジェ ファーマシューティカルズ カンパニー リミテッドＴａｉｗａｎｊ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏ．， Ｌｔｄ． Solid dosage form pharmaceutical formulation of opioid receptor antagonist

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
CA2542836A1 (en) * 2003-10-21 2005-05-12 Alpharma, Inc. Pharmaceutical formulations containing quetiapine
CA2595885A1 (en) * 2005-01-26 2006-08-03 Elan Pharma International Limited Controlled release compositions comprising an antipsychotic agent
US20100056493A1 (en) * 2007-01-25 2010-03-04 Rajesh Jain Modified release pharmaceutical composition and a process of making the same
CN101091700B (en) * 2007-07-03 2011-06-08 上海现代药物制剂工程研究中心有限公司 Composition of slow (controlled) releasing preparation of Quetiadine Hemifumarate, and application
US20110052648A1 (en) * 2008-03-12 2011-03-03 Avi Avramoff Oral modified-release formulations containing thiazepines

Also Published As

Publication number Publication date
EA020477B1 (en) 2014-11-28
WO2010066342A1 (en) 2010-06-17
EP2355804A1 (en) 2011-08-17

Similar Documents

Publication Publication Date Title
EA201000784A1 (en) HEDGEHOG ANTAGONISTS AND THEIR THERAPEUTIC APPLICATIONS
UA110199C2 (en) SOLID RIFAXIMINE DISPERSION
BRPI1009823A2 (en) "composition comprising a drug dispensing system, a first and a second composition set, and a kit."
EA201001332A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
EA201001847A1 (en) COMPOUNDS AND COMPOSITIONS APPLICABLE FOR THE TREATMENT OF MALARIA
TW200740799A (en) Alpha2C adrenoreceptor agonists
EA201171389A1 (en) DOSAGE FORM
BRPI0910503A2 (en) compounds, pharmaceutical compositions and their uses.
BRPI0810646A2 (en) "PHARMACEUTICAL COMPOUNDS".
FR2883179B1 (en) COATED TABLET
BRPI0909084A2 (en) Liquid composition, and, peptide compound.
EA201100084A1 (en) CLEANABLE POLYMER COMPOSITION
EP2191826A4 (en) PHARMACEUTICAL COMPOSITION
ECSP099776A (en) MODULATORS OF THE GAMMA SECRETASA
EA200901653A1 (en) PHY-MEDIATED PHKi INHIBITION OF ALPHA-EnaC EXPRESSION
NO20084850L (en) MGLUR5 modulators I
EA201001330A1 (en) COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS
EA200802111A1 (en) IMPLANTS FOR THE TREATMENT OF THE STATES ASSOCIATED WITH DOPAMIN
BRPI0811893A2 (en) COMPOSITION OF ACRYLIC RUBBER AND VOLCANIZED RUBBER THEREOF, AND THEIR APPLICATIONS.
BRPI0908208A2 (en) Oxazolidinone derivative compound, drug, pharmaceutical composition containing it and use of such compound.
DK2254549T3 (en) AHEAD PHARMACEUTICAL COMPOSITIONS, CONTAINING BORATE-POLYOL COMPLEXS
ECSP11011001A (en) SOLID PHARMACEUTICAL COMPOSITION
CL2007002890A1 (en) Compounds derived from 2-pyridinecarboxamide, glucosinase activator; pharmaceutical composition; and use of the compound for the treatment of diabetes or obesity.
CL2007003232A1 (en) COMPOUNDS DERIVED FROM 5-HYDROXIMETHYL OXAZOLIDIN-2-ONA; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT AND PREVENT BACTERIAL INFECTIONS.
EA201100286A1 (en) COMPOSITION KVETIAPINA

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU